News | October 04, 2025
Briefs: Panacea Biotec, Lotus Eye Hospital and Uflex
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
India currently hosts more than 10,075 biotech startups
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
The Hub & Spoke model is designed to extend advanced medical care to a wider community
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
Subscribe To Our Newsletter & Stay Updated
